Strides Pharma Science is currently trading at Rs. 472.00, up by 25.10 points or 5.62% from its previous closing of Rs. 446.90 on the BSE.
The scrip opened at Rs. 442.20 and has touched a high and low of Rs. 477.00 and Rs. 442.20 respectively. So far 69919 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 511.75 on 30-Jan-2019 and a 52 week low of Rs. 288.00 on 09-Oct-2019.
Last one week high and low of the scrip stood at Rs. 477.00 and Rs. 410.10 respectively. The current market cap of the company is Rs. 4002.12 crore.
The promoters holding in the company stood at 31.28%, while Institutions and Non-Institutions held 47.24% and 21.48% respectively.
Strides Pharma Science has reported a fall of 10.84% in its net profit at Rs 13.65 crore for the quarter ended December 31, 2019 as compared to Rs 15.31 crore for the same quarter in the previous year. Total income of the company decreased by 12.52% at Rs 382.09 crore for Q3FY20 as compared Rs 436.75 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 68% in its net profit attributed to the owners at Rs 93.89 crore for the quarter ended December 31, 2019 as compared to Rs 293.42 crore for the same quarter in the previous year. However, total income of the company increased by 28.49% at Rs 744.66 crore for Q3FY20 as compared Rs 579.54 crore for the corresponding quarter previous year.
